Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada · Delayed Price · Currency is CAD 11.30
-0.15 (-1.31%)
Sep 24, 2026, 10:54 AM EST
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of CAD 754.63 million as of September 24, 2026. Its market cap has increased by 92.06% in one year.
Market Cap
754.63M
Enterprise Value
607.09M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
11.30
ChartMarket Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from 78.01M to 754.63M, an increase of 867.39%. That is a compound annual growth rate of 50.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 754.63M | 44.37% |
| Dec 31, 2025 | 522.69M | 225.34% |
| Dec 31, 2024 | 160.66M | 9.74% |
| Dec 29, 2023 | 146.40M | 85.76% |
| Dec 30, 2022 | 78.81M | 125.87% |
| Dec 31, 2021 | 34.89M | -55.27% |
| Mar 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 854.92M |
| Satellos Bioscience | 269.02M |
| Eastwood Bio-Medical Canada | 126.06M |
| Helix BioPharma | 89.36M |
| NurExone Biologic | 61.69M |
| ME Therapeutics Holdings | 53.18M |
| BriaCell Therapeutics | 49.94M |
| Sona Nanotech | 46.05M |